|
Volumn 166, Issue 16, 2006, Pages 1785-1786
|
Corticosteroids and atrial fibrillation: Risks or benefits? [4]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
C REACTIVE PROTEIN;
CORTICOSTEROID;
GLUCOCORTICOID;
BYPASS SURGERY;
CARDIOVERSION;
CLINICAL PRACTICE;
CLINICAL TRIAL;
CORONARY ARTERY BYPASS GRAFT;
HEART ATRIUM FIBRILLATION;
HEART PROTECTION;
HUMAN;
INFLAMMATION;
LETTER;
PATIENT SELECTION;
POSTOPERATIVE PERIOD;
PRIORITY JOURNAL;
RECURRENT DISEASE;
RISK FACTOR;
DOSE RESPONSE;
NOTE;
OXIDATIVE STRESS;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
ADRENAL CORTEX HORMONES;
ATRIAL FIBRILLATION;
C-REACTIVE PROTEIN;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HUMANS;
INFLAMMATION;
OXIDATIVE STRESS;
RECURRENCE;
|
EID: 33748790093
PISSN: 00039926
EISSN: 15383679
Source Type: Journal
DOI: 10.1001/archinte.166.16.1785-b Document Type: Letter |
Times cited : (1)
|
References (5)
|